STXS
Stereotaxis Inc
$
2.780
Line
|
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
2.930
Open
2.930
VWAP
2.81
Vol
811.20K
Mkt Cap
253.18M
Low
2.695
Amount
2.28M
EV/EBITDA(TTM)
--
Total Shares
82.64M
EV
263.35M
EV/OCF(TTM)
--
P/S(TTM)
7.97
Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory. Its proprietary robotic technology, Robotic Magnetic Navigation (RMN), fundamentally transforms endovascular interventions using precise computer-controlled magnetic fields to directly control the tip of flexible interventional catheters or devices. The Company’s primary products include the Genesis RMN System, the Odyssey Solution, and other related devices. Through its strategic relationships with fluoroscopy system manufacturers, providers of catheters and electrophysiology mapping systems, and other parties, the Company offers its customers x-ray systems and other accessory devices. The Genesis RMN System is designed to enable physicians to complete more complex interventional procedures by providing image-guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites.
Show More
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2026Q1
FY2025Q4
FY2025Q3
12.40M
+65.95%
-0.040
-42.86%
9.87M
+55.63%
-0.055
-38.89%
8.43M
-8.29%
-0.060
-25%
Estimates Revision
The market is revising Upward the revenue expectations for Stereotaxis, Inc. (STXS) for FY2025, with the revenue forecasts being adjusted by 1.47% over the past three months. During the same period, the stock price has changed by 21.40%.
Revenue Estimates for FY2025
Revise Upward
+1.47%
In Past 3 Month
EPS Estimates for FY2025
Revise Downward
-5%
In Past 3 Month
Stock Price
Go Up
+21.40%
In Past 3 Month
4 Analyst Rating
Wall Street analysts forecast STXS stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for STXS is 4.50 USD with a low forecast of 4.00 USD and a high forecast of 5.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
4 Buy
0 Hold
0 Sell
Strong Buy
Current: 2.780
Low
4.00
Averages
4.50
High
5.00
Current: 2.780
Low
4.00
Averages
4.50
High
5.00
The End
No Data
Valuation Metrics
The current forward P/E ratio for Stereotaxis Inc (STXS.A) is -19.40, compared to its 5-year average forward P/E of -18.21. For a more detailed relative valuation and DCF analysis to assess Stereotaxis Inc 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
N/A
5Y Average PE
-18.21
Current PE
-19.40
Overvalued PE
-2.99
Undervalued PE
-33.44
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
N/A
5Y Average EV/EBITDA
-33.88
Current EV/EBITDA
-89.69
Overvalued EV/EBITDA
-4.51
Undervalued EV/EBITDA
-63.26
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
Undervalued
5Y Average PS
6.99
Current PS
2.91
Overvalued PS
10.63
Undervalued PS
3.36
Financials
Annual
Quarterly
FY2025Q2
YoY :
+95.42%
8.80M
Total Revenue
FY2025Q2
YoY :
-25.78%
-4.47M
Operating Profit
FY2025Q2
YoY :
-34.41%
-3.83M
Net Income after Tax
FY2025Q2
YoY :
-28.57%
-0.05
EPS - Diluted
FY2025Q2
YoY :
+20.77%
-3.76M
Free Cash Flow
FY2025Q2
YoY :
-29.27%
52.05
Gross Profit Margin - %
FY2025Q2
YoY :
-27.54%
-27.07
FCF Margin - %
FY2025Q2
YoY :
-66.43%
-43.49
Net Margin - %
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
3
113.6K
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
0.0
Volume
0
0-12
Months
308.8K
Volume
1
Bought
0-3
0
0.0
Volume
Months
3-6
0
0.0
Volume
Months
6-9
0
0.0
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
3
113.6K
USD
Months
0-12
0
0.0
USD
Months
STXS News & Events
Events Timeline
2025-10-15 (ET)
2025-10-15
07:34:05
Stereotaxis Reveals EU Launch and Submits 510k for Synchrony System
2025-10-13 (ET)
2025-10-13
07:40:06
Stereotaxis and CardioFocus Partner to Enhance Robotic PFA Technology
2025-09-22 (ET)
2025-09-22
08:00:03
Stereotaxis reveals Genesis procedures being conducted at Erasmus Medical Center
Sign Up For More Events
Sign Up For More Events
News
7.5
10-13NewsfilterStereotaxis and CardioFocus Partner to Enhance Robotic Pulsed Field Ablation for Heart Rhythm Disorders
5.0
09-23NASDAQ.COMSTXS Shares Rise Following Erasmus Medical's Adoption of Genesis Robotic System
5.0
09-22BenzingaInnovative Robotic System Aims to Enhance Speed and Safety in Arrhythmia Treatment
Sign Up For More News
People Also Watch
SLS
Sellas Life Sciences Group Inc
1.790
USD
-1.65%
HNVR
Hanover Bancorp Inc
21.380
USD
+3.24%
AXR
AMREP Corp
21.610
USD
+0.61%
MNPR
Monopar Therapeutics Inc
84.000
USD
-2.51%
NKTX
Nkarta Inc
2.070
USD
-1.90%
YIBO
Planet Image International Ltd
1.290
USD
+2.38%
FSFG
First Savings Financial Group Inc
29.840
USD
+0.81%
TOYO
TOYO Co., Ltd
7.220
USD
-3.09%
SPKL
Spark I Acquisition Corp
11.469
USD
+0.96%
FAQ
What is Stereotaxis Inc (STXS) stock price today?
The current price of STXS is 2.78 USD — it has decreased -4.47 % in the last trading day.
What is Stereotaxis Inc (STXS)'s business?
What is the price predicton of STXS Stock?
What is Stereotaxis Inc (STXS)'s revenue for the last quarter?
What is Stereotaxis Inc (STXS)'s earnings per share (EPS) for the last quarter?
What changes have occurred in the market's expectations for Stereotaxis Inc (STXS)'s fundamentals?
How many employees does Stereotaxis Inc (STXS). have?